Lexicon collaborator Ipsen receives positive CHMP opinion for Xermelo® (telotristat ethyl)
Lexicon announced the Committee for Medicinal Products for Human Use of the EMA has adopted a positive opinion for the MAA filed by Lexicon collaborator Ipsen for XERMELO® (telotristat ethyl) 250 mg to treat carcinoid syndrome diarrhea in combination with somatostatin analog therapy. July 21, 2017